S&P 500   4,397.94 (-1.89%)
DOW   34,265.37 (-1.30%)
QQQ   351.69 (-2.77%)
AAPL   162.41 (-1.28%)
MSFT   296.03 (-1.85%)
FB   303.17 (-4.23%)
GOOGL   2,607.03 (-2.22%)
AMZN   2,852.86 (-5.95%)
TSLA   943.90 (-5.26%)
NVDA   233.74 (-3.21%)
BABA   123.23 (-5.95%)
NIO   27.35 (-6.11%)
AMD   118.81 (-2.53%)
CGC   7.29 (-3.57%)
MU   81.93 (-3.69%)
GE   96.30 (-1.98%)
T   26.61 (-1.52%)
F   20.65 (-4.62%)
DIS   137.38 (-6.94%)
AMC   17.97 (-0.55%)
PFE   52.79 (-2.33%)
ACB   4.46 (-6.11%)
BA   205.44 (-4.09%)
S&P 500   4,397.94 (-1.89%)
DOW   34,265.37 (-1.30%)
QQQ   351.69 (-2.77%)
AAPL   162.41 (-1.28%)
MSFT   296.03 (-1.85%)
FB   303.17 (-4.23%)
GOOGL   2,607.03 (-2.22%)
AMZN   2,852.86 (-5.95%)
TSLA   943.90 (-5.26%)
NVDA   233.74 (-3.21%)
BABA   123.23 (-5.95%)
NIO   27.35 (-6.11%)
AMD   118.81 (-2.53%)
CGC   7.29 (-3.57%)
MU   81.93 (-3.69%)
GE   96.30 (-1.98%)
T   26.61 (-1.52%)
F   20.65 (-4.62%)
DIS   137.38 (-6.94%)
AMC   17.97 (-0.55%)
PFE   52.79 (-2.33%)
ACB   4.46 (-6.11%)
BA   205.44 (-4.09%)
S&P 500   4,397.94 (-1.89%)
DOW   34,265.37 (-1.30%)
QQQ   351.69 (-2.77%)
AAPL   162.41 (-1.28%)
MSFT   296.03 (-1.85%)
FB   303.17 (-4.23%)
GOOGL   2,607.03 (-2.22%)
AMZN   2,852.86 (-5.95%)
TSLA   943.90 (-5.26%)
NVDA   233.74 (-3.21%)
BABA   123.23 (-5.95%)
NIO   27.35 (-6.11%)
AMD   118.81 (-2.53%)
CGC   7.29 (-3.57%)
MU   81.93 (-3.69%)
GE   96.30 (-1.98%)
T   26.61 (-1.52%)
F   20.65 (-4.62%)
DIS   137.38 (-6.94%)
AMC   17.97 (-0.55%)
PFE   52.79 (-2.33%)
ACB   4.46 (-6.11%)
BA   205.44 (-4.09%)
S&P 500   4,397.94 (-1.89%)
DOW   34,265.37 (-1.30%)
QQQ   351.69 (-2.77%)
AAPL   162.41 (-1.28%)
MSFT   296.03 (-1.85%)
FB   303.17 (-4.23%)
GOOGL   2,607.03 (-2.22%)
AMZN   2,852.86 (-5.95%)
TSLA   943.90 (-5.26%)
NVDA   233.74 (-3.21%)
BABA   123.23 (-5.95%)
NIO   27.35 (-6.11%)
AMD   118.81 (-2.53%)
CGC   7.29 (-3.57%)
MU   81.93 (-3.69%)
GE   96.30 (-1.98%)
T   26.61 (-1.52%)
F   20.65 (-4.62%)
DIS   137.38 (-6.94%)
AMC   17.97 (-0.55%)
PFE   52.79 (-2.33%)
ACB   4.46 (-6.11%)
BA   205.44 (-4.09%)
NASDAQ:SNCE

Science 37 Stock Forecast, Price & News

$8.60
-0.56 (-6.11%)
(As of 01/21/2022 12:00 AM ET)
Add
Compare
Today's Range
$8.52
$9.06
50-Day Range
$8.85
$14.10
52-Week Range
$8.42
$15.10
Volume
112,675 shs
Average Volume
136,648 shs
Market Capitalization
$986.48 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
-0.14
30 days | 90 days | 365 days | Advanced Chart
Receive SNCE News and Ratings via Email

Sign-up to receive the latest news and ratings for Science 37 and its competitors with MarketBeat's FREE daily newsletter.


Science 37 logo

About Science 37

Science 37 Inc. provides operating system for agile clinical trials. Science 37 Inc., formerly known as LifeSci Acquisition II Corp., is based in LOS ANGELES.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Commercial physical research
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:SNCE
Phone
N/A
Fax
N/A
Employees
2
Year Founded
N/A

Sales & Book Value

Annual Sales
N/A
Book Value
$0.22 per share

Profitability

Net Income
$-560 thousand
Pretax Margin
-9.77%

Debt

Price-To-Earnings

Miscellaneous

Free Float
N/A
Market Cap
$986.48 million
Optionable
Not Optionable

Company Calendar

Last Earnings
11/15/2021
Today
1/21/2022
Fiscal Year End
6/30/2022

MarketRank

Overall MarketRank

1.70 out of 5 stars

Medical Sector

950th out of 1,418 stocks

Commercial Physical Research Industry

20th out of 27 stocks

Analyst Opinion: 3.5Community Rank: 5.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -












Science 37 (NASDAQ:SNCE) Frequently Asked Questions

Is Science 37 a buy right now?

4 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Science 37 in the last twelve months. There are currently 4 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Science 37 stock.
View analyst ratings for Science 37
or view top-rated stocks.

How were Science 37's earnings last quarter?

Science 37 Holdings Inc (NASDAQ:SNCE) posted its quarterly earnings data on Monday, November, 15th. The company reported ($3.28) earnings per share for the quarter, beating the consensus estimate of ($5.54) by $2.26. The firm earned $14.24 million during the quarter.
View Science 37's earnings history
.

What guidance has Science 37 issued on next quarter's earnings?

Science 37 issued an update on its FY 2021 earnings guidance on Monday, December, 6th. The company provided EPS guidance of for the period. The company issued revenue guidance of $53.70 million-$54.20 million, compared to the consensus revenue estimate of $52.07 million.

What price target have analysts set for SNCE?

4 Wall Street analysts have issued twelve-month price objectives for Science 37's shares. Their forecasts range from $14.00 to $20.00. On average, they expect Science 37's stock price to reach $16.33 in the next twelve months. This suggests a possible upside of 89.9% from the stock's current price.
View analysts' price targets for Science 37
or view top-rated stocks among Wall Street analysts.

What is Science 37's stock symbol?

Science 37 trades on the NASDAQ under the ticker symbol "SNCE."

How do I buy shares of Science 37?

Shares of SNCE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Science 37's stock price today?

One share of SNCE stock can currently be purchased for approximately $8.60.

How much money does Science 37 make?

Science 37 has a market capitalization of $986.48 million.

How many employees does Science 37 have?

Science 37 employs 2 workers across the globe.

What is Science 37's official website?

The official website for Science 37 is www.lifesciacquisition.com.

Where are Science 37's headquarters?

Science 37 is headquartered at 250 W 55TH ST. #3401, NEW YORK NY, 10019.

How can I contact Science 37?

Science 37's mailing address is 250 W 55TH ST. #3401, NEW YORK NY, 10019. The company can be reached via email at [email protected]sition.com.


This page was last updated on 1/21/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.